Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1985 1
1986 1
1987 1
1989 1
1991 1
1992 1
1995 1
1997 1
1999 2
2000 1
2001 2
2002 2
2003 8
2004 4
2005 6
2006 7
2007 14
2008 15
2009 14
2010 23
2011 22
2012 23
2013 17
2014 21
2015 29
2016 22
2017 31
2018 25
2019 37
2020 31
2021 40
2022 43
2023 33
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

449 results

Results by year

Filters applied: . Clear all
Page 1
Amino acid metabolism in health and disease.
Ling ZN, Jiang YF, Ru JN, Lu JH, Ding B, Wu J. Ling ZN, et al. Among authors: jiang yf. Signal Transduct Target Ther. 2023 Sep 13;8(1):345. doi: 10.1038/s41392-023-01569-3. Signal Transduct Target Ther. 2023. PMID: 37699892 Free PMC article. Review.
Disturbed mitochondrial dynamics in CD8+ TILs reinforce T cell exhaustion.
Yu YR, Imrichova H, Wang H, Chao T, Xiao Z, Gao M, Rincon-Restrepo M, Franco F, Genolet R, Cheng WC, Jandus C, Coukos G, Jiang YF, Locasale JW, Zippelius A, Liu PS, Tang L, Bock C, Vannini N, Ho PC. Yu YR, et al. Among authors: jiang yf. Nat Immunol. 2020 Dec;21(12):1540-1551. doi: 10.1038/s41590-020-0793-3. Epub 2020 Oct 5. Nat Immunol. 2020. PMID: 33020660
Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trial.
Zhao FH, Wu T, Hu YM, Wei LH, Li MQ, Huang WJ, Chen W, Huang SJ, Pan QJ, Zhang X, Hong Y, Zhao C, Li Q, Chu K, Jiang YF, Li MZ, Tang J, Li CH, Guo DP, Ke LD, Wu X, Yao XM, Nie JH, Lin BZ, Zhao YQ, Guo M, Zhao J, Zheng FZ, Xu XQ, Su YY, Zhang QF, Sun G, Zhu FC, Li SW, Li YM, Pan HR, Zhang J, Qiao YL, Xia NS. Zhao FH, et al. Among authors: jiang yf. Lancet Infect Dis. 2022 Dec;22(12):1756-1768. doi: 10.1016/S1473-3099(22)00435-2. Epub 2022 Aug 26. Lancet Infect Dis. 2022. PMID: 36037823 Clinical Trial.
Reply.
Yang X, Tang XP, Zhang YH, Luo KZ, Jiang YF, Luo HY, Lei JH, Wang WL, Li MM, Chen HC, Deng SL, Lai LY, Liang J, Zhang M, Tian Y, Xu Y. Yang X, et al. Among authors: jiang yf. Hepatology. 2016 Oct;64(4):1382-3. doi: 10.1002/hep.28565. Epub 2016 Apr 18. Hepatology. 2016. PMID: 26997619 Free PMC article. No abstract available.
Advances in postoperative adjuvant therapy for primary liver cancer.
Zeng ZM, Mo N, Zeng J, Ma FC, Jiang YF, Huang HS, Liao XW, Zhu GZ, Ma J, Peng T. Zeng ZM, et al. Among authors: jiang yf. World J Gastrointest Oncol. 2022 Sep 15;14(9):1604-1621. doi: 10.4251/wjgo.v14.i9.1604. World J Gastrointest Oncol. 2022. PMID: 36187393 Free PMC article. Review.
449 results